Nanotechnology News

RSS
NanoViricides CEO Presents Lifetime Data from FluCide at Influenza Congress USA 2009

NanoViricides CEO Presents Lifetime Data from FluCide at Influenza Congress USA 2009

XsunX CTO to Discuss Thin-film Technology Breakthroughs During Panel Presentation in Silicon Valley

Organic Semiconductors Researcher Becomes Fellow of APS

Organic Semiconductors Researcher Becomes Fellow of APS

New Database for Material Scientists, Physicists, Chemists and Engineers

Discovery Paves Way for an Entirely New Way to Approach Hydrogen-Storage Problem

Discovery Paves Way for an Entirely New Way to Approach Hydrogen-Storage Problem

Winston-Salem-Based Nanotechnology Company Awarded $100,000 Grant from NC Green Business Fund

Particle Beams Once Again Zooming Around the World's Most Powerful Particle Accelerator

Particle Beams Once Again Zooming Around the World's Most Powerful Particle Accelerator

Introducing SepCon Spin Column for Simple and Precise Separation of Nanoparticles

Hosokawa Micron Announces the Launch of NanoCreator FCM-Mini

Hosokawa Micron Announces the Launch of NanoCreator FCM-Mini

Cavitation Technologies Files Three New PCT Patent

ClassOne Equipment Purchases All Equipment Assets of Colibrys' MEMS Facility in Texas

Berkeley Laboratory Appoints New Director

Berkeley Laboratory Appoints New Director

Overcoming A Major Hurdle in Measuring Zeta Potential of High Concentration Samples

Overcoming A Major Hurdle in Measuring Zeta Potential of High Concentration Samples

Project to Demonstrate World's First Printed Programmable Logic Device

Important Advance in Electrically Controlling Quantum States of Electrons

Important Advance in Electrically Controlling Quantum States of Electrons

News Categories

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.